FIRMM-pix, a brain magnetic resonance imaging (MRI) software module recently launched at the International Society for Magnetic Resonance in Medicine (ISMRM) conference, reportedly employs visual biofeedback and gamification that coaches patients to stay still during brain MRI exams.
Is gamification the answer to reducing motion distortion during brain magnetic resonance imaging (MRI) exams?
Turing Medical Technologies has launched FIRMM-pix, a brain MRI software module, which utilizes gamification and visual biofeedback to ease patient anxiety and reduce head movement during exams.
FIRMM-pix, which was recently showcased at the International Society for Magnetic Resonance in Medicine (ISMRM) conference, reportedly utilizes licensed movie content and a comforting guide dog in one game called Puppy Dreams to help calm patients and inform them about movements during brain MRI exams.
“Motion-induced image degradation remains a significant weakness of brain MRI, making it difficult to acquire a scan quickly. With a solution like FIRMMpix, we have the potential to conduct high-fidelity scans without compromising important data and without the need for anesthesia. Moreover, its patient-centric design fosters active participation, making the scanning process more comfortable and inclusive for patients,” noted Lawrence Tanenbaum, M.D., vice president, chief technology officer and director of advanced imaging at RadNet.
Turing Medical Technologies has launched FIRMM-pix, a brain MRI software module, which utilizes gamification and visual biofeedback to ease patient anxiety and reduce head movement during exams.
Turing Medical Technologies said FIRMM-pix is a complement to the existing FIRMM brain MRI software, which helps monitor head motion during exams and provides real-time feedback to technologists. Use of the FIRMM software can lead to a 25 percent reduction of unnecessary repeat brain MRI scans and greater than $115,000 in annual cost-savings per MRI scanner, according to the company.
(Editor’s note: For related content, see “Can Abbreviated MRI Have an Impact in Neuroimaging?” and “New MRI Study Examines Impact of Disparities with Childhood Adversity Exposure on Brain Development.”)
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
New bpMRI Study Suggests AI Offers Comparable Results to Radiologists for PCa Detection
April 15th 2025Demonstrating no significant difference with radiologist detection of clinically significant prostate cancer (csPCa), a biparametric MRI-based AI model provided an 88.4 percent sensitivity rate in a recent study.
Could Ultrafast MRI Enhance Detection of Malignant Foci for Breast Cancer?
April 10th 2025In a new study involving over 120 women, nearly two-thirds of whom had a family history of breast cancer, ultrafast MRI findings revealed a 5 percent increase in malignancy risk for each second increase in the difference between lesion and background parenchymal enhancement (BPE) time to enhancement (TTE).